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Strong evidence is emerging that the nervous and immune systems share mechanisms of gene regulation,
signaling, cell communication, and supracellular organization. This brings to the fore many questions, not
least of which is the developmental and evolutionary origin of the commonalities between the two systems.
By providing answers to these questions, immunologists and neurobiologists increasingly expose themech-
anistic and conceptual affinities of their respective fields and facilitate the understanding of fundamental prin-
ciples that govern the organization of complex cellular systems. The current essay and reviews in Immunity
and Neuron attempt to communicate to the wider scientific community a series of examples relating to
commonalities between the immune and nervous system and enhance the dialog and exchange of ideas
between the two fields.Over the years, researchers have enter-
tained the idea that the immune and
nervous system of vertebrates bear
intriguing similarities in terms of organiza-
tion and function and have sought to
understand how the two systems are
related. Although the immuneandnervous
systems clearly perform unique functions,
they share developmental mechanisms
and operational modes with many other
tissues and organs throughout the body.
Nevertheless, their emerging commonali-
ties set them apart and suggest that the
immune and nervous systems represent
analogous evolutionary solutions for uni-
que challenges related to monitoring and
responding to changes in the outside
world and the internal environment of an
organism. In the past, neuroimmunology
was concerned mainly with the manner in
which the immune system interacts with
the nervous system in pathological condi-
tions, such as autoimmune disorders.
More recently, however, new levels of
intersection and commonalities have
emerged: for instance, it is now known
that cells within the two systems commu-
nicate viamorphologically similar physical
connections and that they share molec-
ular mediators of communication, such
as transmitters and signaling molecules
(Kerschensteiner et al., 2009). For exam-
ple, neurons and immune cells form
specialized membrane structures called
synapses, or theyhave theability to recog-
nize environmental cues, either specifi-cally (e.g., via surface receptors such as
T and B cell receptors [TCR and BCR]
and the g-amino butyric acid receptor
[GABAR]) or nonspecifically (chemicals,
electric fields), and they respond to
external signals exhibiting a fairly high
degree of plasticity. In addition, cells
from both systems show targeted migra-
tory behavior (neurons mostly, but not
exclusively, during development, immune
cells throughout life). Finally, a very inter-
esting functional characteristic that unites
the two systems is their ability to connect
and carry information from and to distant
parts of the body; neurons using their
long processes (dendrites and axons)
and the immune cells as a result of their
active or passive (via the blood stream)
mobility. What follows is a short, but by
no means exhaustive, list of examples
from an increasing body of work that
highlights someof the similarities between
the nervous and immune systems. Two
reviews in this issue of Immunity and an
accompanying issue of Neuron (volume
64, number 1) have recognized the
increase in interest covering the common-
alities between the two systems and
responded by publishing a series of more




Soluble molecules and their respective
receptors expressed by either or bothImmunity 31, Nimmune and neuronal cells play important
roles in functional aspects of the two
systems, e.g., the two cell types are able
to ‘‘talk’’ to each other and to diverse
cell types via soluble ligands and their
receptors. This type of nonsynaptic com-
munication in many cases is bidirectional,
given that both types of interacting
cells produce the same molecules and
carry the same receptors or they produce
or bear receptors and ligands in a comple-
mentary fashion. The use of common
communication machineries within these
cells underlines the evolution of a com-
mon chemical language. Molecules that
mediate this type of communication
include cytokines, chemokines, neuro-
peptides, neurotransmitters, neurotro-
phins (Camacho-Arroyo et al., 2009), and
their receptors (Levite, 2008; Selmeczy
et al., 2008).
Cytokines and their receptors are a
prime example of a bidirectional commu-
nication system. Originally, they were
found to be made by immune cells and
to affect the development and function of
other cells within that system. However,
later they were shown to be produced
also by cells of the nervous system (micro-
glia, astrocytes, and neurons) controlling
fundamental aspects of function and
development, such as the switch from
neurogenesis to gliogenesis in the cortex
(Miller and Gauthier, 2007). This intricate
interplay gave rise to the notion that the
brain can play an immunoregulatory roleovember 20, 2009 ª2009 Elsevier Inc. 705
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affect neuronal activity (Kerschensteiner
et al., 2009).
The complex and versatile language
that has been deciphered from studies
on chemokines and their receptors has
been appropriated and exploited effec-
tively by the nervous and immune sys-
tems. The impressively extensive chatter
generated by these molecules has proven
an invaluable tool in the communication
between homologous and heterologous
cell classes, as well as in the coordination
of their function. There are numerous
members of these gene families that most
likely arose from duplication of ancestral
genes and that were adapted to different
functions as evolution progressed. Thus,
they have emerged as another example,
in which notions of exclusive use by one
system, i.e., lymphoid cells that utilized
chemokines in cell trafficking and immune
responses, were revised by findings that
chemokines and their receptors, such as
CXCL12-CXCR4, play an important role in
neuronal cell migration and development
(Li and Ransohoff, 2008; Tiveron and
Cremer, 2008). A comprehensive review
by Richard Ransohoff on the fascinating
role of chemokines in development and
cell-cell communication within the nervous
and immune systems appears in this issue
of Immunity (Ransohoff, 2009).
The list of common surface molecules
involved in environmental recognition
has been expanded in recent years to
include Toll-like receptors (TLRs), which
were also thought originally to be primarily
functioning in immune cells but are now
also found in neuronal cells, in which
they appear to perform a cell-autono-
mous function (Farina et al., 2007). Thus,
cells in the CNS appear to be activated
via TLR8 by ligands that are not of bacte-
rial origin but that are induced during
injury, autoimmune situations, hypoxia,
and neurodegeneration (Kielian, 2006;
Ma et al., 2007). Moreover, TLR8 stimula-
tion has been associated with suppres-
sion of neurite outgrowth and induction
of apoptosis. Stimulation of another of
these receptors, TLR3, after viral infection
also seems to trigger an ‘‘immune’’-type
response by neurons characterized by
cytokine production (Prehaud et al.,
2005).
The case of neuropeptides, which are
produced by and affect cells of both
types, present a particularly interesting706 Immunity 31, November 20, 2009 ª200aspect of communication between the
immune and nervous systems. Thus,
neuropeptide Y (NPY), once thought to
be made exclusively in the central and
peripheral nervous systems (CNS and
PNS), was recently found to be produced
also by lymphocytes. By triggering its
receptor Y1, this peptide appears to
generate pleiotropic effects on cell migra-
tion, cytokine release, and antibody
production, thus playing an important
role in autoimmunity and inflammation
processes (Wheway et al., 2007). A similar
situation can be described concerning
endocannabinoids that affect immune
responses and play a role in adult neuro-
genesis (Wolf and Ullrich, 2008).
In addition to communication and
response to the environment based on
nonsynaptic signals, information and in-
structions are transferred between cells
of the nervous and immune systems by
specialized membrane structures result-
ing from the concerted interaction of
surface molecules on the communicating
cells (Dustin and Colman, 2002; Shaw
and Allen, 2001). The term ‘‘synapse’’ is
traditionally used to define these struc-
tures in the nervous system, and the adop-
tion of the term by immunobiologists
undoubtedly reflects the shared ability of
the interacting immune and neuronal cells
to form extended communication surface
platforms. This commonality is further
reinforced by the finding that agrin,
a matrix molecule, forms part of the struc-
ture in both types of synapses (Khan et al.,
2001). In addition to synapses formed
between homologous cells (i.e., between
neurons or immune cells), the formation
of such specific structures between
neurons and lymphoid cells has also
been postulated or described (Hanisch
and Kettenmann, 2007; Tian et al., 2009).
For example, physical contacts between
the two cell types are seen in pathophysi-
ological situations, such as autoimmune
conditions in which lymphoid cells attack
cells of the nervous system. Although their
physical basis is still unclear, physiological
heterologous connections have also been
described in lymphoid organs in which
sympathetic innervation and production
of neuropeptides or norepinephrine
appear to have an effect on the function
of the lymphoid cells found in this organ.
It would be interesting to study the inter-
communication between the systems
during remodeling of lymphoid organs in9 Elsevier Inc.immune responses. It is unclear how this
is achieved at this moment, but undoubt-
edly synaptic communication as well as
cytokines and neuromodulatory
substances will be found to form an intri-
cate network of communication pathways
that affect both types of cells (Sloan et al.,
2008).
Motility, Plasticity, and Barriers
Similarities between the two systems are
also found in the rules that govern the
motility and directionality of movement
of the neurons and immune cells. For
instance, both types of cells are able to
map a precise itinerary in response to
attractive and repulsive signals produced
by other cells present along their migra-
tory route or at the final destination.
Thus, lymphocyte movement within
lymphoid organs appears to be the result
of recognition ofmolecules and structures
produced and laid down by stroma cells in
a precise fashion (Bajenoff et al., 2006).
Neurons migrate and extend their
processes also through complex stromal
structures after specialized signals that
include semaphorins, signaling molecules
that are key players in neuronal guidance,
and that recently were found to be ex-
pressed and used also by lymphocytes
(Mizui et al., 2009).
Plasticity in developmental fates is
another characteristic common to both
systems. Depending on the environ-
mental cues, cells from either system
adopt oneof amultiplicity of differentiation
options (Allen, 2008; Jessell, 2000). Neural
crest cells are an extreme example, in
which multilineage progenitors can differ-
entiate toward diverse cell types such as
neurons and glia, perivascular cells, bone,
cartilage, or smooth muscle (Foster et al.,
2008; Le Douarin and Kalcheim, 1999).
Similarly, in the immune system T cells
candevelopdiverse functional characteris-
tics, becoming cells with different tasks
within an immune response (Th1, Th2,
Th17 cell, etc.) (Wilson et al., 2009). An
extrememanifestationofplasticity issome-
times seen in cells that have committed to
one subset, but reverse this decision and
acquire another functional identity (Landis
et al., 1988; Zhou et al., 2009).
Organisms constantly evolve in the
context of their environment, which is
generally hostile. To protect themselves
from assaults, multicellular organisms
have developed tissues, which confer
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stimuli. For example, the epidermis of
the skin and the epithelial lining of the gut
protect nonspecifically the internal envi-
ronment of the organism from invading
agents. In addition, however, both the
immune and nervous systems have been
implicated in the formation of even more
sophisticated and active barriers between
the circulating blood and the CNS, on
one hand, and between the intestinal
content and the rest of the organism, on
the other. The principle (with appropriate
modifications) of the two barriers is basi-
cally the same: they are both composed
of a physical barrier (epithelium in the
gut, endothelium in the brain) supported
and regulated underneath by a communi-
cation cellular network that involves
hemopoietic cells (lymphocyte, dendritic
cells, and macrophages) or cells of the
nervous system (glia). The immune cells
are thought to act as surveyors of and
responders to the threatening agents.
Even though the cellular components of
the physical barriers in the two systems
derive from different embryonic layers,
they share functional and morphological
characteristics suggesting a common
mechanism that evolved to protect and
selectively isolate certain parts of the
body fromothers. The intriguingmolecular
and physical similarities, as well as the
dissimilarities that differentiate the two
barriers, are the subject of a revealing
review by Daneman and Rescigno in this
issue of Immunity (Daneman and Re-
scigno, 2009).
Development
In addition to the similarities in phenotypic
and behavioral traits described above,
recent advances have led to discoveries
of shared molecular mechanisms under-
lying developmental processes. In this
respect, it was found recently that RET,
a tyrosine kinase receptor and thought
to be critical for the development of the
intrinsic nervous system of the gut, was
found to be essential for lymphoid organ-
ogenesis in the same organ (Veiga-Fer-
nandes et al., 2007). This raised the
interesting possibility that multicellular,
multiorgan life forms may utilize similar
molecular tools to orchestrate the devel-
opment and architectural organization of
diverse tissues within the same organ. In
this particular case, RET is required for
the migration of neural crest cells in thegut wall and their differentiation and
aggregation to form the ganglia of the
enteric neural plexus. Interestingly, RET
was also found to be important for the
development of Peyer’s patch primordia
formed by the aggregation of hemopoietic
cells that colonize the gut wall during
embryogenesis. An interesting question
arising from this observation is why the
two systems, despite utilizing the same
molecular mechanism, do not get con-
fused, but instead, their respective struc-
tures end up in the right position with the
gut wall, i.e., the myenteric plexus in close
association with the smooth muscle
layers and Peyer’s patches in the submu-
cosa of the intestinal wall. A possible
explanation may lie in the fact that RET
has multiple ligands and coreceptors
forming diverse activation axes (Airaksi-
nen et al., 2006), which might be dif-
ferentially utilized by the nervous and
hemopoietic systems during develop-
ment. Thus, RET ligand GDNF and its
cognate coreceptor GFRa1 are important
for the formation of the enteric nervous
system, but are not required for the
formation of Peyer’s patch primordia. It
is possible, therefore, that differential
temporal and spatial availability of ligands
and coreceptors underlies the differential
response via RET within the two systems.
Cellular and Genomic Organization
Regarding the molecular mechanisms that
govern cytoskeletal organization and
signaling functions, it was shown that
a common scaffolding protein, the micro-
tubule-organizing center protein RanBPM,
is expressed and utilized by both types of
cells. This protein with its multiple func-
tional domains appears to have pleiotropic
functions within both systems, including
neurite branching (Brunkhorst et al.,
2005), association with adhesion mole-
cules (Cheng et al., 2005; Denti et al.,
2004), and signaling in the cytoplasm of
lymphoid cells (Murrin and Talbot, 2007).
Via its capacity to interact with plexins, it
is also thought to be involved in the
responses to attractive or repulsive signals
provided bymolecules such as semaphor-
ins (Togashi et al., 2006).
At the genomic and transcriptional
level, the NF-kB and Ikaros families are
prime examples of transcription factors
that have profound roles in the develop-
ment and function of both types of cells
(Agoston et al., 2007; Ng et al., 2007; PizziImmunity 31, Net al., 2009; Vallabhapurapu and Karin,
2009; West et al., 2002). The Aryl hydro-
carbon receptor (AHR) is a member of
the basic helix loop helix (bHLH) family
of regulators and was thought to be a
receptor for exogenous ligands. Recently,
however, it was shown to respond also to
endogenous ligands playing an important
role in normal physiology and develop-
ment of both nervous and immune
systems (McMillan and Bradfield, 2007;
Stockinger et al., 2009).
Even more intriguing is the case of
a specialized type of gene regulation
known generally as ‘‘allelic exclusion.’’
Cell types from both systems have devel-
oped a mechanism that allows the
expression of only one gene out of a large
array of similar genes. At the same time,
the rest of the genes found on the same
chromosome or its allele or even on
another chromosome and belonging to
the same family are silenced. Olfactory
receptor genes in the nervous system
and antigen-specific receptor genes in
B and T cells are the most extensively
studied examples of such selective ex-
pression and silencing process employed
by both systems (Cedar and Bergman,
2008; Serizawa et al., 2004).
In recent years, epigenetics have also
come to the fore in studies on chromatin
regulation and gene expression. At the
moment, there are no tissue-specific
chromatin modifications that can be
attributed to particular systems, but it
would be interesting to see in the future
whether the two systems employ com-
mon chromatin remodelling mechanisms
during development or pathological con-




The similarities between the nervous and
the immune systems described so far
raise a more fundamental evolutionary
question: did they evolve independently
from each other but happened to co-opt
functions from each other, or did they
evolve from a common ancestral cell
that could recognize and interpret the
environment, communicate with other
cells, and exhibit plasticity (Figure 1)?
In a recent review, Arendt presented an
overviewof such aquestion andproposed
that cells from different organs that show
functional similarities may have eitherovember 20, 2009 ª2009 Elsevier Inc. 707
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(Arendt, 2008). Arendt presented hypoth-
eses of how the different cell types diver-
sify during the evolution of organs. Recent
progresses of genome-wide interrogation
of organisms, organs, and cell types have
allowed the collection of cell-type-specific
molecular fingerprints (mainly transcrip-
tion-factor-expression programs) that
have revealed shared mechanisms allow-
ing the building of relationship trees. Cell
typeswith commonmolecular fingerprints
could have arisen from an ancient cell that
was multifunctional and whose functions
were subsequently differentially distrib-
uted to sister daughter cell types as
a result of the loss of specific transcription
factor expression (segregation of func-
tion). Alternatively, the generation of new
cell types could have been engendered
by retention—accompanied by modifica-
tion of function—of ancestral genes in
the descendant sister cell types (diver-
gence of function) or by acquisition of
gene expression cascades from other
cells.
In many cases, divergence of function
involved duplication of genes, which
subsequently acquired modifications that
differentiated their function. This becomes
pertinent in the example of RET signaling
mechanism discussed above. RET recog-
nizes four structurally related ligands
and utilizes four structurally related core-
ceptors that very likely arose from the
duplication of ancestral genes (Airaksinen
et al., 2006). By developing specificity for
particular ligand-coreceptor combina-
tions, different types of cells can utilize
similar molecular language (i.e., RET
signaling), but still retain their individuality.
The same could be said about different
lineage cells utilizing different members
of the gene family that encode PAX
(Holland and Short, 2008; Ransohoff,
2009; Rothenberg and Pant, 2004) or the
chemokine-chemokine receptor system
(Ransohoff, 2009).
During the examination of such molec-
ular fingerprints, it has become obvious
that B and T cells in the immune sys-
tem arose from the same ancestral
progenitor, and consistent with the idea
of ‘‘development recapitulating evolution’’
in vertebrates, the B and T cell lineages
also develop from a common lymphoid
progenitor in the bone marrow. It may be
interesting to utilize such bioinformatic
tools to examine the hypothesis that
immune and nervous cells share a
common evolutionary progenitor.
Future Challenges: Memory
Similar to the arbitrary common use of the
word ‘‘synapse’’ by both fields, which was
in the end justified by showing that these
structures share molecular characteris-
tics, one could provocatively invoke the
use of the word ‘‘memory’’ by both immu-
nologists and neurobiologists as further
indication of underlying common mecha-
nisms. In concept, the word in both
systems relays the notion that cells
‘‘remember’’ what they had experienced
in the past and can recall these experi-
ences again given the right stimulus. In
the recall response, speed andmagnitude
are of the essence. During the response of
a memory lymphoid cell, events, such as
acquisition of effector functions, happen
much more quickly than during the
primary response to antigen. In long-
term potentiation (LTP) the establishment
of memory means that upon restimula-
tion, neurons respond according to their
previous experience. Is it possible that
the often increased response in neurons
is partly governed by molecular mecha-
nisms also operating in immune cells?
Future Challenges: Higher-Order
Organization
Most tissues and organs are made up of
one or at most a few distinct cell types.
Contrary to that, the immune and nervous
systems contain a plethora of different cell
types that have been adapted to perform
specific functions. Thus, the immune
system is made up of a large number of
lymphocytes, dendritic cells, or macro-
phages that are specialized in monitoring
the internal milieu and external environ-
ment of the organism and in responding
to it. Similar to the immune system, the
nervous system is made up of many
neuronal subtypes that can be identified
by uniquemorphological and neurochem-
ical characteristics. Neurons of the same
subtype are often organized into ‘‘nuclei’’
(observed mostly in the central nervous
system), but it is also the case that many
different type of neurons are intermixed
in a salt-and-pepper fashion without any
apparent logic (as is often the case in the


















Figure 1. Possible Evolutionary Schemes for the Immune and Nervous Systems
As shown on the top, the two systems evolved from independent evolutionary ancestors with the
co-option of different transcriptional programs from one another. As shown on the bottom, the two
systems evolved from a common evolutionary ancestor that diverged toward two more specialized
systems after silencing or activating of different transcriptional programs.708 Immunity 31, November 20, 2009 ª2009 Elsevier Inc.
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characterized by anatomical compart-
ments (e.g., B cell follicles, T cell areas)
that mainly contain functionally similar
types of lymphoid cells; however, even in
these compartments, one encounters
many different types of immune cells that
are actively or passively intermixed. The
complex character of the immune and
nervous systems, as manifested in the
large variety of identity, function, and
connectivity of the different cellular
subtypes, confers a nonlinear functionality
that is critical for the complex activities of
both systems. A major challenge in the
future will be to understand the molecular
mechanisms, which control the organiza-
tion and spatial distribution of this large
array of specialized immune or neuronal
subtypes.
Future Challenges: Networks
Both the immune and nervous systems
have characteristically developed an intri-
cate network of cellular specializations
and interactions, which allow them to
actively monitor the environment and
sense specific changes in physical or
chemical parameters, process the input,
and produce an output that is appropriate
for and specific to the inducing or initiating
signal. Over the last decades, we have
learned a lot about the cellular andmolec-
ular basis of the receiving (‘‘sensory’’) and
responding (‘‘motor’’) legs of this func-
tional arc. The challenge ahead of us is
to understand the integrative processes
that lie in between, namely how ‘‘sensory’’
information received by specialized
neuronal and immune cells is processed
by an intricate network of interneurons
or specialized lymphocytes to produce
specific ‘‘motor’’ responses (such as
muscle contraction or activation of the
appropriate immune effector cells) that
are particular for a given signal. Integral
to the proper function of such networks
are regulatory cells and mechanisms
that have been developed and whose
role is to modulate the response of cells
within the nervous and lymphoid systems.
It would be important to assess how these
regulatory or inhibitory cells evolved and
whether the molecular mechanisms
employed by them share any compo-
nents. Live imaging of whole organs has
contributed, and will continue to con-
tribute, immensely in our understanding
how the two systems orchestrate theirfunctions as multicellular networks of
units with diverse functions. Is it possible
that new parallels and similarities will
emerge from studying the function of the
systems at a higher integrative level?
Immunology and neurosciences are
well established and highly active re-
search disciplines. The molecular mecha-
nisms underlying diverse cellular pro-
cesses in the immune and nervous
system are being defined at a remarkable
pace and critical players and pathways
are being uncovered in both systems by
applying new tools and approaches. This
overview highlighted recent examples
that suggest a certain degree of mecha-
nistic and conceptual convergence of
the two fields. The excitement of future
research relies on uncovering the com-
mon rules and principles that determine
the assembly and function of the immune
and nervous system and the extent to
which such laws might apply to other
complex cellular networks.
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